The Thames Valley region is at the heart of the wider ‘Golden Triangle’, which links Oxford with London and Cambridge – one of the densest clusters in Europe, comparable to international super-clusters such as the one in Massachusetts.
The life sciences roundtable series is chaired by Simon Greenstreet of Bayer and attended by senior representatives from life sciences companies across the region, including corporates, SMEs, new and established inward investors; Government; Local Enterprise Partnerships, academia; and the NHS. Topics previously discussed have included skills; links between education and business and improving connectivity between corporates and start-up companies.
During the most recent event in the series, keynote speaker, Harjinder Kang, Director Healthcare, Life Sciences & Bio Economy, Department for International Trade, outlined the UK Government’s priorities in delivering the Life Sciences Industrial Strategy and Sector Deal and how Thames Valley life sciences organisations can get involved. Roundtable participants also provided an update on the aims, objectives, challenges and aspirations of the group.
Life Sciences Partnership
Following a Life Sciences Roundtable discussion in 2018, the Thames Valley Life Sciences Partnership was established at the invitation of Government, in order to contribute proposals to the Life Sciences Sector Deal, part of the Government’s Industrial Strategy. The Partnership is coordinated by Thames Valley Chamber and is also chaired by Simon Greenstreet. The roundtable series supports and contributes to the work of the Partnership, whose members are drawn from roundtable participants.
The strength of the Thames Valley’s Life Sciences sector, including the work of the Partnership, was highlighted in the UK Government’s Life Sciences Sector Deal 2.